Review



human npnt expression  (TaKaRa)


Bioz Verified Symbol TaKaRa is a verified supplier
Bioz Manufacturer Symbol TaKaRa manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    TaKaRa human npnt expression
    Real‐time PCR primer sequences.
    Human Npnt Expression, supplied by TaKaRa, used in various techniques. Bioz Stars score: 95/100, based on 593 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human npnt expression/product/TaKaRa
    Average 95 stars, based on 593 article reviews
    human npnt expression - by Bioz Stars, 2026-06
    95/100 stars

    Images

    1) Product Images from "Antibodies against nephronectin ameliorate anti‐type II collagen‐induced arthritis in mice"

    Article Title: Antibodies against nephronectin ameliorate anti‐type II collagen‐induced arthritis in mice

    Journal: FEBS Open Bio

    doi: 10.1002/2211-5463.12758

    Real‐time PCR primer sequences.
    Figure Legend Snippet: Real‐time PCR primer sequences.

    Techniques Used: Real-time Polymerase Chain Reaction, Sequencing

    Primer sequences for cloning of Npnt.
    Figure Legend Snippet: Primer sequences for cloning of Npnt.

    Techniques Used: Cloning, Sequencing

    Npnt neutralization by anti‐Npnt‐FD antibody ameliorates CAIA. (A) Protocol for CAIA with anti‐Npnt‐FD antibody treatment. The antibody was administered to BALB/c mice on days −4 and 0 relative to LPS injection during CAIA induction. (B) Npnt expression in arthritic joints on day 6, synovial fibroblasts, or synovial macrophages were evaluated by real‐time PCR. * P < 0.05, ** P < 0.01, wild‐type versus CAIA (Student's t ‐test). (C) Arthritis scores of arthritic mice treated with control antibody (rabbit IgG) or an anti‐Npnt‐FD antibody at the indicated time points ( n = 5 per group). * P < 0.05, ** P < 0.01, anti‐Npnt‐FD antibody versus control Ig (Student's t ‐test). Data are presented as means ± SEM. (D) Representative images of the forepaw and hindpaw on day 7 are shown. (E–G) Representative histology of normal joints and arthritic joints on day 14 from mice treated with control antibody or anti‐Npnt‐FD antibody. Sections were stained with HE (E, G) or Safranin‐O (F). Magnified views of the boxed areas a and b are shown in F and G, respectively. Scale bar = 2mm (E), 200μm (F and G). Data are representative of three or more independent experiments with similar results.
    Figure Legend Snippet: Npnt neutralization by anti‐Npnt‐FD antibody ameliorates CAIA. (A) Protocol for CAIA with anti‐Npnt‐FD antibody treatment. The antibody was administered to BALB/c mice on days −4 and 0 relative to LPS injection during CAIA induction. (B) Npnt expression in arthritic joints on day 6, synovial fibroblasts, or synovial macrophages were evaluated by real‐time PCR. * P < 0.05, ** P < 0.01, wild‐type versus CAIA (Student's t ‐test). (C) Arthritis scores of arthritic mice treated with control antibody (rabbit IgG) or an anti‐Npnt‐FD antibody at the indicated time points ( n = 5 per group). * P < 0.05, ** P < 0.01, anti‐Npnt‐FD antibody versus control Ig (Student's t ‐test). Data are presented as means ± SEM. (D) Representative images of the forepaw and hindpaw on day 7 are shown. (E–G) Representative histology of normal joints and arthritic joints on day 14 from mice treated with control antibody or anti‐Npnt‐FD antibody. Sections were stained with HE (E, G) or Safranin‐O (F). Magnified views of the boxed areas a and b are shown in F and G, respectively. Scale bar = 2mm (E), 200μm (F and G). Data are representative of three or more independent experiments with similar results.

    Techniques Used: Neutralization, Injection, Expressing, Real-time Polymerase Chain Reaction, Control, Staining



    Similar Products

    human npnt expression  (TaKaRa)
    95
    TaKaRa human npnt expression
    Real‐time PCR primer sequences.
    Human Npnt Expression, supplied by TaKaRa, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human npnt expression/product/TaKaRa
    Average 95 stars, based on 1 article reviews
    human npnt expression - by Bioz Stars, 2026-06
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Real‐time PCR primer sequences.

    Journal: FEBS Open Bio

    Article Title: Antibodies against nephronectin ameliorate anti‐type II collagen‐induced arthritis in mice

    doi: 10.1002/2211-5463.12758

    Figure Lengend Snippet: Real‐time PCR primer sequences.

    Article Snippet: For human Npnt expression in human tissues, a human multiple tissue cDNA panel was used (Takara, Kusatsu, Japan).

    Techniques: Real-time Polymerase Chain Reaction, Sequencing

    Primer sequences for cloning of Npnt.

    Journal: FEBS Open Bio

    Article Title: Antibodies against nephronectin ameliorate anti‐type II collagen‐induced arthritis in mice

    doi: 10.1002/2211-5463.12758

    Figure Lengend Snippet: Primer sequences for cloning of Npnt.

    Article Snippet: For human Npnt expression in human tissues, a human multiple tissue cDNA panel was used (Takara, Kusatsu, Japan).

    Techniques: Cloning, Sequencing

    Npnt neutralization by anti‐Npnt‐FD antibody ameliorates CAIA. (A) Protocol for CAIA with anti‐Npnt‐FD antibody treatment. The antibody was administered to BALB/c mice on days −4 and 0 relative to LPS injection during CAIA induction. (B) Npnt expression in arthritic joints on day 6, synovial fibroblasts, or synovial macrophages were evaluated by real‐time PCR. * P < 0.05, ** P < 0.01, wild‐type versus CAIA (Student's t ‐test). (C) Arthritis scores of arthritic mice treated with control antibody (rabbit IgG) or an anti‐Npnt‐FD antibody at the indicated time points ( n = 5 per group). * P < 0.05, ** P < 0.01, anti‐Npnt‐FD antibody versus control Ig (Student's t ‐test). Data are presented as means ± SEM. (D) Representative images of the forepaw and hindpaw on day 7 are shown. (E–G) Representative histology of normal joints and arthritic joints on day 14 from mice treated with control antibody or anti‐Npnt‐FD antibody. Sections were stained with HE (E, G) or Safranin‐O (F). Magnified views of the boxed areas a and b are shown in F and G, respectively. Scale bar = 2mm (E), 200μm (F and G). Data are representative of three or more independent experiments with similar results.

    Journal: FEBS Open Bio

    Article Title: Antibodies against nephronectin ameliorate anti‐type II collagen‐induced arthritis in mice

    doi: 10.1002/2211-5463.12758

    Figure Lengend Snippet: Npnt neutralization by anti‐Npnt‐FD antibody ameliorates CAIA. (A) Protocol for CAIA with anti‐Npnt‐FD antibody treatment. The antibody was administered to BALB/c mice on days −4 and 0 relative to LPS injection during CAIA induction. (B) Npnt expression in arthritic joints on day 6, synovial fibroblasts, or synovial macrophages were evaluated by real‐time PCR. * P < 0.05, ** P < 0.01, wild‐type versus CAIA (Student's t ‐test). (C) Arthritis scores of arthritic mice treated with control antibody (rabbit IgG) or an anti‐Npnt‐FD antibody at the indicated time points ( n = 5 per group). * P < 0.05, ** P < 0.01, anti‐Npnt‐FD antibody versus control Ig (Student's t ‐test). Data are presented as means ± SEM. (D) Representative images of the forepaw and hindpaw on day 7 are shown. (E–G) Representative histology of normal joints and arthritic joints on day 14 from mice treated with control antibody or anti‐Npnt‐FD antibody. Sections were stained with HE (E, G) or Safranin‐O (F). Magnified views of the boxed areas a and b are shown in F and G, respectively. Scale bar = 2mm (E), 200μm (F and G). Data are representative of three or more independent experiments with similar results.

    Article Snippet: For human Npnt expression in human tissues, a human multiple tissue cDNA panel was used (Takara, Kusatsu, Japan).

    Techniques: Neutralization, Injection, Expressing, Real-time Polymerase Chain Reaction, Control, Staining